Get the Stockscreener App
0.7524
16.54%
-0.1491
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Forecast
The Scinai Immunotherapeutics Ltd Adr (SCNI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.88, representing a +1,877% increase from the current price of $0.7524. The highest analyst price target is $17.07, and the lowest is $12.69.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SCNI Price Target
Average 25.72
(+3,318% Upside)
Is Scinai Immunotherapeutics Ltd Adr (SCNI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.32 | Buy |
| STOCH(9,6) | 17.84 | Buy |
| STOCHRSI(14) | 10.85 | Buy |
| MACD(12,26) | -0.2849 | Sell |
| ADX(14) | 14.93 | Neutral |
| William %R | -98.02 | Buy |
| CCI(14) | -88.96 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.0924
Sell
|
1.0771
Sell
|
| MA20 |
1.3427
Sell
|
1.2941
Sell
|
| MA50 |
1.9122
Sell
|
1.8187
Sell
|
| MA100 |
2.486
Sell
|
2.781
Sell
|
| MA200 |
4.8282
Sell
|
5.3765
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SCNI could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on SCNI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.32 indicates that SCNI is oversold. This indicates that SCNI price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 17.84 indicates that SCNI is oversold. This indicates that SCNI price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.85 indicates that SCNI is oversold. This suggests that SCNI price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.93 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -88.96 indicates that SCNI is still oversold but not to an extreme extent.
Long-term SCNI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Scinai Immunotherapeutics Ltd Adr financial reports and earnings history, Scinai Immunotherapeutics Ltd Adr (SCNI) stock could reach $5.2998 by 2030, $76.50 by 2040 and $223.16 by 2050. See the projected annual prices until 2050 of the Scinai Immunotherapeutics Ltd Adr stock below:
- Scinai Immunotherapeutics Ltd Adr (SCNI) is expected to reach an average price of $149.98 in 2035, with a high prediction of $150.34 and a low estimate of $149.57. This indicates an $19,833% rise from the last recorded price of $0.7524.
- Scinai Immunotherapeutics Ltd Adr (SCNI) stock is projected to chart a bullish course in 2040, with an average price target of $71.21, representing an $9,364% surge from its current level. The forecast ranges from a conservative $71.72 to a sky-high $76.50.
- Our analysts predict Scinai Immunotherapeutics Ltd Adr (SCNI) to jump 54,207% by 2045, soaring from $413.20 to an average price of $408.61, potentially reaching $410.17. While $413.20 is the low estimate, the potential upside is significant.
- Scinai Immunotherapeutics Ltd Adr (SCNI) stock is expected to climb by 2050, reaching an average of $210.21, a $27,839% jump from its current level. However, a wide range of estimates exists, with high and low targets of $223.16 and $211.01, respectively, highlighting the market's uncertainty.
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Year by Year Forecast
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2026
The predicted value for Scinai Immunotherapeutics Ltd Adr (SCNI) in 2026 is set at an average of $20.24. Estimates vary from a peak of $39.75 to a trough of $0.732, indicating an +2,590% surge from the present price of $0.7524.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $32.06 | $12.69 | $17.07 | +4,161% |
| December, 2026 | $28.95 | $31.01 | $25.96 | +3,747% |
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Scinai Immunotherapeutics Ltd Adr (SCNI) is $29.29, with a high forecast of $38.75 and a low forecast of $19.82. This indicates an +3,792% increase from the last price of $0.7524.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $19.82 | $19.82 | $25.43 | +2,535% |
| February, 2027 | $29.70 | $27.66 | $22.70 | +3,848% |
| March, 2027 | $37.55 | $32.08 | $30.91 | +4,891% |
| April, 2027 | $33.84 | $35.38 | $31.17 | +4,398% |
| May, 2027 | $28.38 | $32.26 | $28.40 | +3,672% |
| June, 2027 | $32.38 | $34.21 | $29.86 | +4,203% |
| July, 2027 | $31.04 | $33.01 | $30.23 | +4,025% |
| August, 2027 | $37.39 | $38.19 | $35.28 | +4,869% |
| September, 2027 | $27.37 | $29.45 | $38.75 | +3,537% |
| October, 2027 | $33.10 | $29.91 | $27.75 | +4,299% |
| November, 2027 | $32.14 | $29.39 | $30.19 | +4,171% |
| December, 2027 | $27.97 | $31.27 | $26.70 | +3,618% |
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2028
In 2028, Scinai Immunotherapeutics Ltd Adr (SCNI) is projected to reach an average price of $21.91, with a high projection of $26.44 and a low estimate of $17.39. This indicates an +2,812% rise from the last price of $0.7524.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $26.12 | $26.12 | $25.62 | +3,372% |
| February, 2028 | $25.20 | $26.30 | $24.93 | +3,249% |
| March, 2028 | $24.08 | $24.48 | $24.01 | +3,101% |
| April, 2028 | $20.26 | $21.31 | $23.15 | +2,593% |
| May, 2028 | $17.51 | $19.67 | $17.55 | +2,227% |
| June, 2028 | $16.59 | $17.39 | $16.68 | +2,105% |
| July, 2028 | $27.89 | $23.11 | $26.44 | +3,606% |
| August, 2028 | $20.02 | $20.02 | $20.51 | +2,560% |
| September, 2028 | $18.19 | $17.43 | $18.11 | +2,318% |
| October, 2028 | $19.01 | $19.84 | $19.34 | +2,427% |
| November, 2028 | $24.32 | $18.95 | $16.05 | +3,133% |
| December, 2028 | $20.80 | $22.20 | $22.89 | +2,665% |
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2029
The 2029 price forecast for Scinai Immunotherapeutics Ltd Adr Stock (SCNI) is $13.42 on average, with a high prediction of $20.42 and a low estimate of $6.41. This represents an +1,683% increase from the previous price of $0.7524.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $20.95 | $19.18 | $20.17 | +2,685% |
| February, 2029 | $18.03 | $18.83 | $20.42 | +2,296% |
| March, 2029 | $20.12 | $17.47 | $18.61 | +2,575% |
| April, 2029 | $19.36 | $16.39 | $18.68 | +2,473% |
| May, 2029 | $17.52 | $17.84 | $18.23 | +2,228% |
| June, 2029 | $14.70 | $14.25 | $14.92 | +1,854% |
| July, 2029 | $13.26 | $13.36 | $13.96 | +1,662% |
| August, 2029 | $12.24 | $12.53 | $12.77 | +1,527% |
| September, 2029 | $8.7232 | $10.99 | $11.32 | +1,059% |
| October, 2029 | $8.972 | $8.8199 | $8.5325 | +1,092% |
| November, 2029 | $8.8411 | $8.7814 | $8.0486 | +1,075% |
| December, 2029 | $6.40 | $6.41 | $8.0199 | +750.61% |
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2030
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) is expected to reach an average price of $59.22 in 2030, with a high forecast of $117.90 and a low forecast of $0.5448. This signifies an +7,771% surge from the last price of $0.7524.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.3591 | $4.3771 | $5.2998 | +346.45% |
| February, 2030 | $2.7982 | $2.8582 | $2.8186 | +271.90% |
| March, 2030 | $1.0073 | $1.0673 | $1.3177 | +33.88% |
| April, 2030 | $105.37 | $0.5448 | $96.37 | +13,905% |
| May, 2030 | $126.12 | $123.19 | $111.13 | +16,663% |
| June, 2030 | $120.89 | $124.01 | $117.90 | +15,967% |
| July, 2030 | $105.28 | $109.65 | $116.84 | +13,892% |
| August, 2030 | $117.33 | $116.43 | $113.35 | +15,494% |
| September, 2030 | $120.84 | $122.18 | $116.17 | +15,961% |
| October, 2030 | $112.90 | $115.71 | $113.92 | +14,906% |
| November, 2030 | $108.66 | $112.54 | $109.12 | +14,342% |
| December, 2030 | $109.75 | $112.08 | $108.38 | +14,486% |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):